2Ray,Kausik K,Cannon et al. Intensive statin therapy in acute coronary syndromes: Clinical benefits and vascular biology[J]. Current Opinion in Lipidology,2004,15 (6) : 637～ 643.
3ch(o)nbeck,Uwe,Libby et al. Inflammation,immunity,and HMG-CoA reductase inhibitors:Statins as antiinflammatory agents [J]. Circulation, 2004: 109 (21):Ⅱ -18～Ⅱ-26.
4Walter,Dirk H,Zeiher et al. Effects of statins on endothelium and their contribution to neovascularization by mobilization of endothelial progenitor cells [J]. Coronary Artery Disease, 2004, 15 (5): 235 ～242.
5Naghavi,Morteza,Libby. From vulnerable plaque to vulnerable patient :A call for new definitions and risk assessment strategies [J]. Circulation, 2003,108 (14):1664～1672.
6Gomberg-Maitland, Mardi, Fuster et al. Statins and plaque stability [J]. Journal of Cardiovascular Risk,2003,10(3): 161～167.
7Aikawa. Effects of statin therapy on vascular dysfunction [J]. Coronary Artery Disease, 2004,15 ( 5 ):227～233.
8Chen Jiawei,Li Dayuan,Schaefer et al. Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in Apo-E knockout mice :Novel insights into the role of RAS and dyslipidemia in atherogenesis [J]. Cardiovascular Pharmacology,2004,44 (4): 446 ～ 452.
